| Outcome Measures: |
Primary: Percentage Change Rate From Baseline in the Modification of Diet in Renal Disease(MDRD) Estimated Glomerular Filtration Rate (eGFR) at Week 24 After Routine Care of Pravastatin Administration, The following formula was used to calculate MDRD eGFR: MDRD eGFR (mL/min/1.73 m\^2) = 186 x (serum creatinine) -1.154 x (age)-0.203 x (0.742 if female), Week 24 post-dose | Secondary: Change from Baseline in Modification of Diet in Renal Disease (MDRD) Estimated Glomerular Filtration Rate (eGFR) at Week 24 After Routine Care of Pravastatin Administration, The following formula was used to calculate MDRD eGFR: MDRD eGFR (mL/min/1.73 m\^2) = 186 x (serum creatinine)\^-1.154 x (age)\^-0.203 x (0.742 if female), Week 24 post-dose|Percentage Change Rate from Baseline in Modification of Diet in Renal Disease (MDRD) Estimated Glomerular Filtration Rate (eGFR) at Week 12 and Week 48 After Routine Care of Pravastatin Administration, The following formula was used to calculate MDRD eGFR: MDRD eGFR (mL/min/1.73 m\^2) = 186 x (serum creatinine)\^-1.154 x (age)\^-0.203 x (0.742 if female), Week 12 and Week 48 post-dose|Change from Baseline in Modification of Diet in Renal Disease (MDRD) Estimated Glomerular Filtration Rate (eGFR) at Week 12 and Week 48 after Routine Care of Pravastatin Administration, The following formula was used to calculate MDRD eGFR: MDRD eGFR (mL/min/1.73 m\^2) = 186 x (serum creatinine)\^-1.154 x (age)\^-0.203 x (0.742 if female), Week 12 and Week 48 post-dose|Percentage Change Rate from Baseline in Estimated Glomerular Filtration Rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI) Formula at Week 12, Week 24, and Week 48 After Routine Care of Pravastatin Administration, The following formula was used to calculate CKD-EPI eGFR: CKD-EPI eGFR (mL/min/1.73 m\^2) = 141 × min (serum creatinine/k, 1)\^α × max (serum creatinine/k, 1)\^-1.209 × 0.993\^(age) × 1.018 (if female), where k is 0.7 for females and 0.9 for males, α is -0.329 for females and -0.411 for males, min indicates minimum serum creatinine/k or 1, and max indicates maximum serum creatinine/k or 1., Week 12, Week 24, and Week 48 post-dose|Change from Baseline in Estimated Glomerular Filtration Rate (eGFR) using the Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI) Formula at Week 12, Week 24, and Week 48 After Routine Care of Pravastatin Administration, The following formula was used to calculate CKD-EPI eGFR: CKD-EPI eGFR (mL/min/1.73 m\^2) = 141 × min (serum creatinine/k, 1)\^α × max (serum creatinine/k, 1)\^-1.209 × 0.993\^(age) × 1.018 (if female), where k is 0.7 for females and 0.9 for males, α is -0.329 for females and -0.411 for males, min indicates minimum serum creatinine/k or 1, and max indicates maximum serum creatinine/k or 1., Week 12, Week 24, and Week 48 post-dose|Percentage Change Rate from Baseline in Total Cholesterol, Low Density Lipoprotein Cholesterol, High Density Lipoprotein-Cholesterol, Triglycerides, Fasting Plasma Glucose at Week 12, Week 24, and Week 48 After Routine Care of Pravastatin Administration, Blood plasma samples will be collected to assess lipids (total cholesterol \[mg/dL\], low density lipoprotein cholesterol (LDL-C) \[mg/dL\], high density lipoprotein-cholesterol (HDL-C) \[mg/dL\], triglyceride \[mg/dL\], and fasting plasma glucose \[mg/dL\])., Week 12, Week 24, and Week 48 post-dose|Change from Baseline in Total Cholesterol, Low Density Lipoprotein Cholesterol, High Density Lipoprotein-Cholesterol, Triglycerides, Fasting Plasma Glucose at Week 12, Week 24, and Week 48 After Routine Care of Pravastatin Administration, Blood plasma samples will be collected to assess lipids (total cholesterol \[mg/dL\], low density lipoprotein cholesterol (LDL-C) \[mg/dL\], high density lipoprotein-cholesterol (HDL-C) \[mg/dL\], triglyceride \[mg/dL\], and fasting plasma glucose \[mg/dL\])., Week 12, Week 24, and Week 48 post-dose|Percentage Change Rate from Baseline in Hemoglobin A1c (HbA1c) at Week 12, Week 24 and Week 48 After Routine Care of Pravastatin Administration, Blood plasma samples will be collected to assess hemoglobin A1c (HbA1c) (%)levels., Week 12, Week 24, and Week 48 post-dose|Change from Baseline in Hemoglobin A1c (HbA1c) at Week 12, Week 24 and Week 48 After Routine Care of Pravastatin Administration, Blood plasma samples will be collected to assess hemoglobin A1c (HbA1c) (%)levels., Week 12, Week 24, and Week 48 post-dose|Number of Participants With Treatment-emergent Adverse Events After Routine Care of Prevastatin Administration, Treatment-emergent adverse event (TEAE) is defined as an event that emerges during treatment, having been absent pretreatment, or worsens relative to the pretreatment state., Week 48 post-dose
|
| Locations: |
Korea University Ansan Hospital, Ansan, 15355, Korea, Republic of|The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon, 14647, Korea, Republic of|Yeongnam University Medical Center, Busan, 42415, Korea, Republic of|Inje University Busan Paik Hospital - Site 23, Busan, 47392, Korea, Republic of|Inje University Busan Paik Hospital - Site 26, Busan, 47392, Korea, Republic of|Bong Seng Memorial Hospital, Busan, 48775, Korea, Republic of|Pusan National University Hospital - Site 43, Busan, 49241, Korea, Republic of|Pusan National University Hospital - Site 49, Busan, 49241, Korea, Republic of|Kosin University Gospel Hospital, Busan, 49267, Korea, Republic of|Changwon Fatima Hospital, Changwon, 51394, Korea, Republic of|Soon Chun Hyang University Cheonan Hospital, Cheonan, 31151, Korea, Republic of|Daegu Catholic University Medical Center, Daegu, 42472, Korea, Republic of|Eulji University DaeJeon Medical Center, Daejeon, 35233, Korea, Republic of|Konyang University Hospital, Daejeon, 35365, Korea, Republic of|GangNeung Asan Hospital, Gangneung, 25440, Korea, Republic of|Dongguk University Ilsan Hospital, Goyang, 10326, Korea, Republic of|Inje University Ilsan Paik Hospital, Goyang, 10380, Korea, Republic of|National Health Insurance Service Ilsan Hospital, Goyang, 10444, Korea, Republic of|Myongji Hospital, Goyang, 10475, Korea, Republic of|Chosun University Hospital, Gwangju, 61453, Korea, Republic of|Gwangju Veterans Hospital, Gwangju, 62284, Korea, Republic of|Gachon University Gil Medical Center, Incheon, 21565, Korea, Republic of|Bundang CHA General Hospital, Seongnam, 13496, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam, 13620, Korea, Republic of|HANIL General Hospital, Seoul, 01450, Korea, Republic of|Korea Cancer Center Hospital, Seoul, 01812, Korea, Republic of|Eulji University Medical Center - Site 20, Seoul, 01830, Korea, Republic of|Eulji University Medical Center - Site 52, Seoul, 01830, Korea, Republic of|Seoul Medical Center, Seoul, 02053, Korea, Republic of|The Catholic University of Korea, St. Paul's Hospital, Seoul, 02559, Korea, Republic of|Yonsei University Health System, Severance Hospital, Seoul, 03722, Korea, Republic of|Soon Chun Hyang University Seoul Hospital, Seoul, 04401, Korea, Republic of|Kyung Hee University Hospital at Gangdong, Seoul, 05278, Korea, Republic of|Kangdong Sacred Heart Hospital, Seoul, 05355, Korea, Republic of|VHS Medical Center, Seoul, 05368, Korea, Republic of|Yonsei University Health System, Gangnam Severance Hospital, Seoul, 06273, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Chung-Ang Univerisity Hospital, Seoul, 06973, Korea, Republic of|The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, 07345, Korea, Republic of|St. Carollo General Hospital, Suncheon, 57931, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital - Site 45, Suwon, 16247, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital - Site 50, Suwon, 16247, Korea, Republic of|Ajou University Hospital - Site 04, Suwon, 16499, Korea, Republic of|Ajou University Hospital - Site 05, Suwon, 16499, Korea, Republic of|Dongkang Medical Center, Ulsan, 44455, Korea, Republic of|Yonsei University, Wonju Severance Christian Hospital - Site 10, Wŏnju, 26426, Korea, Republic of|Yonsei University, Wonju Severance Christian Hospital - Site 15, Wŏnju, 26426, Korea, Republic of
|
